Home

Annual Meeting 2018

Latest Discussions

  • This a challenging case with limited anticoagulation options. While warfarin remains the mainstay anticoagulant in thrombotic APS (at least until ongoing RCTs of DOACs in APS demonstrate equivalent efficacy/safety), you could consider starting Dabigatran ...

  • Dear HSIG members, The management of acute and chronic pain in Sickle Cell Disease can be challenging.  This has become even more of an issue for some patients and physicians in the setting of the current opioid crisis and the recent governmental restrictions ...

  • Dear ASPHO Community, The management of acute and chronic pain in Sickle Cell Disease can be challenging.  This has become even more of an issue for some patients and physicians in the setting of the current opioid crisis and the recent governmental ...

Announcements

Most Active Members